Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	50,212	24,469	39,363	52,994	15,643	11,641
Market Cap Growth	41.03%	-37.84%	-25.72%	238.77%	34.38%	-88.15%
Enterprise Value	53,006	25,800	38,574	53,964	18,909	14,449
Last Close Price	990.00	482.45	776.10	1044.85	383.25	285.20

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	170.29	245.70	29.14	57.50	33.77	-
Forward PE	51.76	24.18	29.60	41.04	-	-
PS Ratio	5.89	1.99	2.82	6.47	2.35	2.08
PB Ratio	3.90	1.56	2.53	4.53	2.27	1.80
P/TBV Ratio	4.14	1.64	2.56	4.59	2.27	1.80
P/FCF Ratio	-	-	-	86.62	-	14.91
P/OCF Ratio	39.97	19.48	76.63	42.06	85.30	12.59
PEG Ratio	-	0.87	0.77	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.22	2.09	2.76	6.59	2.84	2.58
EV/EBITDA Ratio	89.09	55.62	25.76	49.33	22.57	27.21
EV/EBIT Ratio	223.75	635.57	35.64	69.52	65.22	-
EV/FCF Ratio	-	-	-	88.21	-	18.51

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.28	0.20	0.10	0.12	0.48	0.41
Debt / EBITDA Ratio	5.97	6.52	1.02	1.23	3.96	5.05
Debt / FCF Ratio	-	-	-	2.21	-	3.43
Net Debt / Equity Ratio	0.22	0.19	0.09	0.11	0.44	0.41
Net Debt / EBITDA Ratio	4.60	6.46	0.89	1.20	3.64	4.97
Net Debt / FCF Ratio	-	-1.13	-1.30	2.15	-4.58	3.38
Asset Turnover	-	0.57	0.77	0.59	0.57	0.48
Inventory Turnover	-	2.12	2.56	2.04	2.00	2.01
Quick Ratio	-	0.80	0.75	0.79	0.65	0.73
Current Ratio	-	1.89	2.16	3.04	1.35	1.65
Return on Equity (ROE)	-	0.64%	9.92%	9.92%	7.95%	-9.29%
Return on Assets (ROA)	-	0.12%	3.73%	3.49%	1.55%	-1.80%
Return on Capital Employed (ROCE)	-	0.20%	6.90%	6.00%	3.40%	-3.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	0.59%	0.41%	3.43%	1.74%	2.96%	-0.17%
FCF Yield	-5.26%	-10.79%	-2.60%	1.15%	-4.26%	6.71%
Buyback Yield / Dilution	0.08%	-	-23.82%	-18.49%	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error